Navigation Links
BioMarin Announces Fourth Quarter and Full Year 2010 Financial Results
Date:2/17/2011

ed earnings per share includes the 19.1 million shares related to our outstanding convertible debt at December 31, 2010. The calculation of GAAP diluted earnings per share for the fourth quarter of 2010 and the 2009 periods presented exclude the 19.1 million and 26.3 million shares, respectively, related to our convertible debt outstanding at December 31, 2010 and 2009, respectively, as their impact is considered anti-dilutive.

The calculation of non-GAAP diluted earnings per share for the fourth quarter and year ended December 31, 2010 excludes the 19.1 million shares related to the Company's convertible debt outstanding on December 31, 2010, as their impact is considered anti-dilutive. The calculation of non-GAAP diluted earnings per share for the year ended December 31, 2009 excludes 26.3 million shares related to the Company's outstanding convertible debt, as their impact is considered anti-dilutive. The calculation of non-GAAP diluted earnings per share for the fourth quarter of 2009 includes 26.3 million shares related to the Company's outstanding convertible debt, as their impact is considered dilutive.

Conference Call DetailsBioMarin will host a conference call and webcast to discuss fourth quarter and full year 2010 financial results today, Thursday, February 17, at 5:00 p.m. ET. This event can be accessed on the investor section of the BioMarin website at www.BMRN.com.

Date: February 17, 2011Time: 5:00 p.m. ET U.S. / Canada Dial-in Number:  866.203.3206International Dial-in Number:  617.213.8848Participant Code: 90635895Replay Dial-in Number: 888.286.8010Replay International Dial-in Number: 617.801.6888Replay Code: 22192303About BioMarinBioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises four approved products and multiple clinical and pre-clinical product candidates. Approved products inc
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. BioMarin Initiates Pivotal Phase 3 Trial for GALNS for the Treatment of MPS IVA
2. BioMarin to Host Fourth Quarter and Full Year 2010 Financial Results
3. BioMarin Initiates Phase 1/2 Trial for BMN 701 for the Treatment of Pompe Disease
4. BioMarin Initiates Phase 1/2 Trial for BMN 673 for the Treatment of Genetically-Defined Cancers
5. BioMarin to Present at the J.P. Morgan 29th Annual Healthcare Conference
6. BioMarin to Present at the Deutsche Bank 2010 BioFEST Conference
7. BioMarin Completes Partial Exchange of Convertible Notes Due 2013 for Common Stock
8. BioMarin Announces Third Quarter 2010 Financial Results
9. BioMarin to Host a Research and Development Day on October 19th
10. BioMarin Appoints William Young and Kenneth Bate to Its Board of Directors
11. BioMarin to Present at the UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014 As health officials across the Midwest warn ... pharmacies in Michigan will offer free ... enabling Meijer pharmacists to administer tests and, in some cases, ... physician participating in the study. The ...
(Date:1/15/2014)... 2014  Novation, the leading health care supply chain expertise, ... reseller (VAR) national contracts that expand its portfolio to ... lower costs. These include manufacturer product and service agreements, ... and ongoing IT consulting support. New ...
(Date:1/15/2014)... , Jan. 15, 2014 Massachusetts General Hospital ... AMGN ) announced today that they have ... validate new therapeutic targets and develop novel therapies ... that affects millions worldwide. The MGH-Broad-Amgen collaboration brings ...
Breaking Medicine Technology:Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4
... 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Inc. (NYSE Amex: ... specializes in the development and sale of patented ... generics and active pharmaceutical ingredients (API) announced that ... Macrolide Facility (JCM) has passed the internal quality ...
... NEW YORK, Nov. 9, 2011 ... research report is available in its ... and Reimbursement in Europe - Reference ... to Innovative Drugs Pose Significant Challenge ...
Cached Medicine Technology:JCM Passes Internal Quality Assessment for Azithromycin API Production 2JCM Passes Internal Quality Assessment for Azithromycin API Production 3Pharmaceutical Pricing and Reimbursement in Europe - Reference Pricing and Similar Initiatives Being Applied to Innovative Drugs Pose Significant Challenge to Pharmaceutical Companies 2Pharmaceutical Pricing and Reimbursement in Europe - Reference Pricing and Similar Initiatives Being Applied to Innovative Drugs Pose Significant Challenge to Pharmaceutical Companies 3Pharmaceutical Pricing and Reimbursement in Europe - Reference Pricing and Similar Initiatives Being Applied to Innovative Drugs Pose Significant Challenge to Pharmaceutical Companies 4Pharmaceutical Pricing and Reimbursement in Europe - Reference Pricing and Similar Initiatives Being Applied to Innovative Drugs Pose Significant Challenge to Pharmaceutical Companies 5Pharmaceutical Pricing and Reimbursement in Europe - Reference Pricing and Similar Initiatives Being Applied to Innovative Drugs Pose Significant Challenge to Pharmaceutical Companies 6Pharmaceutical Pricing and Reimbursement in Europe - Reference Pricing and Similar Initiatives Being Applied to Innovative Drugs Pose Significant Challenge to Pharmaceutical Companies 7
(Date:7/11/2014)... -- Delaying surgery to repair damage to the anterior cruciate ... the knee -- could increase a young athlete,s risk for ... of 130 patients, aged 8 to 16, who had ACL ... six weeks after their injury, 37 had surgery six to ... three months after their injury. The youngsters who had ...
(Date:7/11/2014)... VA (PRWEB) July 11, 2014 Riverside Health ... Care (CBCC) in Virginia in late 2012 and now, ... ChooseHome – to residents throughout the Williamsburg and Newport News ... programs provide services and benefits to independent older adults who ... access to a safety net of continuing care services as ...
(Date:7/11/2014)... For many years scientists have been trying to unravel ... cells, those cells that generate all blood cells including ... cells is difficult because they can only be found ... be recapitulated in a culture dish. Now a group ... Prof. Claudia Waskow (Technische Universitt Dresden) was able to ...
(Date:7/11/2014)... 2014 WWTrek Human Outreach Project ... Community in Tanzania. Opened in 2012, the KKC is now ... cows. HOP Founder, Dean Cardinale, started the KKC to create ... orphaned children he encountered while running treks on Tanzania's Mount ... who have all made astounding progress in school over the ...
(Date:7/11/2014)... New research from UC San Francisco shows that ... Medea Project helps women living with HIV disclose ... self-efficacy and the safety and quality of their ... study,s first author, Edward L. Machtinger, MD, director ... 90 percent of our patients are on effective ...
Breaking Medicine News(10 mins):Health News:Delaying Kid's Knee Surgery Could Be a Bad Play, Study Finds 2Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 2Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 3Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 4Health News:Opening-up the stem cell niche 2Health News:Human Outreach Project Sees Incredible Progress in the Kilimanjaro Kids Community 2Health News:'Expressive therapy" intervention assists women living with HIV 2
... Transplant Week to raise awareness of the growing imbalance between ... number of people// awaiting transplants. ,Statistics show that ... joined the Organ Donor Register. In addition it has been ... 2,200 actually operations took place. ,The NHS has ...
... of the fetus is more accurately detected by ultra sound ... that Rh diseases of the fetus are more accurately detected ... blood flow in the middle cerebral artery, which is the ... were of the feeling that as ultrasound is an non-invasive ...
... said that around 176 babies are born each minute ... of World Population Day//. The program was organized by ... Grameen Arogya Abhiyan in Bangalore. ,"With the increase ... Population should be controlled in the interest of a ...
... large-scale study published in the July issue of the urology ... use of Uprima// , a drug known to treat problems ... rates of this drug. ,And 70 per cent ... National Health Service (NHS) drug feedback form felt the drug ...
... early as possible in an effort to reverse its ... leading// cause of disability in people over the age ... have been able to treat the disease and offer ... identified telltale, genetic signs that indicate the early onset ...
... the release of salaries of doctors participating in the anti-quota stir ... that the order to do so was issued on the direction ... V P Gupta, who was asked to explain the reason behind ... Venugopal., ,Gupta was asked to relinquish charge as Registrar by ...
Cached Medicine News:Health News:National Transplant Week to Raise Need for Organ Donation 2Health News:Doppler USG-Safer Technique For Detection Of Rh Diseases In Fetus 2Health News:Erection Drug Was Not Useful to Two-Thirds of Its Users 2Health News:Erection Drug Was Not Useful to Two-Thirds of Its Users 3Health News:Researchers Beginning to Identify Genetic Culprits of Arthritis 2
Adson bipolar forceps, 12 cm, straight....
Straight, blunt and pointed tips....
Angulated, blunt and pointed tips....
Blunt, 20 cm long....
Medicine Products: